New Research Points to Fresh Understanding of Alzheimer’s Disease

Scientists in the United States have proposed a new theory that could reshape understanding of how Alzheimer’s disease develops, offering potential new directions for future treatments and research.

Researchers at the University of California, Riverside suggest that Alzheimer’s may begin not with the formation of the amyloid plaques that have long been considered a hallmark of the disease, but with a disruption occurring inside brain cells when two proteins compete for the same role.

For decades, Alzheimer’s research has focused heavily on amyloid beta, a protein that accumulates in the brains of people living with the condition. However, despite significant investment in therapies designed to remove amyloid deposits, many treatments have shown only limited success in slowing or reversing disease progression.

The new study highlights a possible interaction between amyloid beta and another protein, tau, which plays a crucial role in maintaining the internal transport system of nerve cells. Tau normally helps stabilise microtubules – tiny structures that act as transport pathways, carrying essential materials throughout neurons.

According to the researchers, amyloid beta may be capable of attaching to these same microtubules. Laboratory experiments found that the two proteins bind to microtubules with similar strength, raising the possibility that increasing levels of amyloid beta could displace tau from its normal position.

If this occurs, the consequences could be significant. The disruption of microtubules may impair the ability of neurons to transport nutrients and other vital materials. At the same time, tau may begin to accumulate abnormally and move into areas of the cell where it would not normally be found, contributing to the changes associated with Alzheimer’s disease.

The researchers believe this mechanism could explain why both amyloid beta and tau build up in the brain, while also helping to account for the limited success of treatments that focus solely on removing amyloid plaques. Under this model, the visible plaques and tangles associated with Alzheimer’s may be consequences of deeper cellular dysfunction rather than the original trigger of the disease.

The theory also aligns with evidence showing that the brain’s natural waste-removal process, known as autophagy, becomes less effective with age. As this cellular “housekeeping” system slows, amyloid beta may accumulate inside neurons, increasing the likelihood of interference with tau and microtubule function.

Researchers noted that previous studies linking lithium use with a reduced risk of Alzheimer’s may also support the hypothesis, as lithium has been shown to help stabilise microtubules. While further research is needed, this observation suggests that protecting the cell’s transport network could become a future therapeutic target.

For the care sector, the findings underline the complexity of Alzheimer’s disease and the continuing importance of research into its underlying causes. Although the study does not immediately change clinical practice, it may eventually help guide the development of treatments aimed at preventing cellular damage before the characteristic symptoms of dementia emerge.

The research was published in the journal PNAS Nexus and provides a new framework for understanding how the disease may develop at the cellular level, potentially opening the door to more effective